Valuation: Acarix AB

Market Cap 297M 30.88M 26.89M 25.08M 23.08M 43.35M 2.95B 44.37M 116M 1.46B 116M 113M 5.08B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 297M 30.88M 26.89M 25.08M 23.08M 43.35M 2.95B 44.37M 116M 1.46B 116M 113M 5.08B EV / Sales 2026 *
15.6x
EV / Sales 2027 * 4.28x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-0.40%
1 week+2.04%
Current month-1.57%
1 month-4.93%
3 months-11.17%
6 months+1.01%
Current year-6.53%
1 week 0.24
Extreme 0.2395
0.26
1 month 0.23
Extreme 0.232
0.26
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.45
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.72
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%+2.04%-35.93%-50.69% 30.8M
+1.44%+3.87%+17.53%-38.48% 15.69B
+0.63%+10.05%+0.58%+99.42% 1.74B
-1.02%+0.43%-36.76%-81.06% 1.14B
+0.88%-1.57%-37.79%+14.13% 976M
+2.34%+2.73%-44.06%-53.05% 633M
+1.73%+1.89%-46.79%-56.39% 517M
-1.62%+2.15%+38.61%-52.49% 470M
+2.26%+1.93%-55.19%-60.00% 376M
+5.68%+5.39%-15.50%-31.11% 355M
Average +1.19%+3.06%-21.53%-30.97% 2.19B
Weighted average by Cap. +1.27%+1.74%+6.21%-28.79%

Financials

2026 *2027 *
Net sales 19.1M 1.98M 1.73M 1.61M 1.48M 2.78M 190M 2.85M 7.47M 93.84M 7.44M 7.28M 326M 69.5M 7.21M 6.28M 5.86M 5.39M 10.13M 690M 10.37M 27.17M 341M 27.07M 26.49M 1.19B
Net income -28.9M -3M -2.61M -2.44M -2.24M -4.21M -287M -4.31M -11.3M -142M -11.26M -11.01M -494M 2.4M 249K 217K 202K 186K 350K 23.82M 358K 938K 11.79M 935K 915K 41M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
29/07/26 SEK 0.2505 -0.40% 886,675
28/07/26 SEK 0.2515 +1.82% 1,069,871
27/07/26 SEK 0.2470 +0.20% 437,653
24/07/26 SEK 0.2465 +0.41% 430,102
23/07/26 SEK 0.2455 +0.20% 588,338

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock